These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 21456052)
1. Inhibitory effects of ketoconazole and rifampin on OAT1 and OATP1B1 transport activities: considerations on drug-drug interactions. Choi MK; Jin QR; Choi YL; Ahn SH; Bae MA; Song IS Biopharm Drug Dispos; 2011 Apr; 32(3):175-84. PubMed ID: 21456052 [TBL] [Abstract][Full Text] [Related]
2. Increased systemic exposure of fimasartan, an angiotensin II receptor antagonist, by ketoconazole and rifampicin. Kim JW; Yi S; Kim TE; Lim KS; Yoon SH; Cho JY; Lee MG; Song IS; Shin SG; Jang IJ; Yu KS J Clin Pharmacol; 2013 Jan; 53(1):75-81. PubMed ID: 23400746 [TBL] [Abstract][Full Text] [Related]
4. OATP1B1, OATP1B3, and mrp2 are involved in hepatobiliary transport of olmesartan, a novel angiotensin II blocker. Nakagomi-Hagihara R; Nakai D; Kawai K; Yoshigae Y; Tokui T; Abe T; Ikeda T Drug Metab Dispos; 2006 May; 34(5):862-9. PubMed ID: 16501004 [TBL] [Abstract][Full Text] [Related]
5. Investigation of the impact of substrate selection on in vitro organic anion transporting polypeptide 1B1 inhibition profiles for the prediction of drug-drug interactions. Izumi S; Nozaki Y; Maeda K; Komori T; Takenaka O; Kusuhara H; Sugiyama Y Drug Metab Dispos; 2015 Feb; 43(2):235-47. PubMed ID: 25414411 [TBL] [Abstract][Full Text] [Related]
6. Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver. Vavricka SR; Van Montfoort J; Ha HR; Meier PJ; Fattinger K Hepatology; 2002 Jul; 36(1):164-72. PubMed ID: 12085361 [TBL] [Abstract][Full Text] [Related]
7. Substrate-dependent inhibition of organic anion transporting polypeptide 1B1: comparative analysis with prototypical probe substrates estradiol-17β-glucuronide, estrone-3-sulfate, and sulfobromophthalein. Izumi S; Nozaki Y; Komori T; Maeda K; Takenaka O; Kusano K; Yoshimura T; Kusuhara H; Sugiyama Y Drug Metab Dispos; 2013 Oct; 41(10):1859-66. PubMed ID: 23920221 [TBL] [Abstract][Full Text] [Related]
9. Organic anion transporting polypeptide-mediated transport of, and inhibition by, asunaprevir, an inhibitor of hepatitis C virus NS3 protease. Eley T; Han YH; Huang SP; He B; Li W; Bedford W; Stonier M; Gardiner D; Sims K; Rodrigues AD; Bertz RJ Clin Pharmacol Ther; 2015 Feb; 97(2):159-66. PubMed ID: 25670521 [TBL] [Abstract][Full Text] [Related]
10. Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3. Noé J; Portmann R; Brun ME; Funk C Drug Metab Dispos; 2007 Aug; 35(8):1308-14. PubMed ID: 17470528 [TBL] [Abstract][Full Text] [Related]
11. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3. Gozalpour E; Greupink R; Wortelboer HM; Bilos A; Schreurs M; Russel FG; Koenderink JB Mol Pharm; 2014 Jun; 11(6):1844-55. PubMed ID: 24754247 [TBL] [Abstract][Full Text] [Related]
12. In vitro assessment of drug-drug interaction potential of boceprevir associated with drug metabolizing enzymes and transporters. Chu X; Cai X; Cui D; Tang C; Ghosal A; Chan G; Green MD; Kuo Y; Liang Y; Maciolek CM; Palamanda J; Evers R; Prueksaritanont T Drug Metab Dispos; 2013 Mar; 41(3):668-81. PubMed ID: 23293300 [TBL] [Abstract][Full Text] [Related]
13. Prediction of the in vivo OATP1B1-mediated drug-drug interaction potential of an investigational drug against a range of statins. Sharma P; Butters CJ; Smith V; Elsby R; Surry D Eur J Pharm Sci; 2012 Aug; 47(1):244-55. PubMed ID: 22538052 [TBL] [Abstract][Full Text] [Related]
14. Validation of cell-based OATP1B1 assays to assess drug transport and the potential for drug-drug interaction to support regulatory submissions. Sharma P; Holmes VE; Elsby R; Lambert C; Surry D Xenobiotica; 2010 Jan; 40(1):24-37. PubMed ID: 19919292 [TBL] [Abstract][Full Text] [Related]
15. Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport. Kindla J; Müller F; Mieth M; Fromm MF; König J Drug Metab Dispos; 2011 Jun; 39(6):1047-53. PubMed ID: 21389119 [TBL] [Abstract][Full Text] [Related]
16. Long-lasting inhibitory effects of saquinavir and ritonavir on OATP1B1-mediated uptake. Shitara Y; Takeuchi K; Horie T J Pharm Sci; 2013 Sep; 102(9):3427-35. PubMed ID: 23440887 [TBL] [Abstract][Full Text] [Related]
17. Further characterization of the electrogenicity and pH sensitivity of the human organic anion-transporting polypeptides OATP1B1 and OATP1B3. Martinez-Becerra P; Briz O; Romero MR; Macias RI; Perez MJ; Sancho-Mateo C; Lostao MP; Fernandez-Abalos JM; Marin JJ Mol Pharmacol; 2011 Mar; 79(3):596-607. PubMed ID: 21173039 [TBL] [Abstract][Full Text] [Related]
18. Expression of organic anion-transporting polypeptides 1B1 and 1B3 in ovarian cancer cells: relevance for paclitaxel transport. Svoboda M; Wlcek K; Taferner B; Hering S; Stieger B; Tong D; Zeillinger R; Thalhammer T; Jäger W Biomed Pharmacother; 2011 Sep; 65(6):417-26. PubMed ID: 21719246 [TBL] [Abstract][Full Text] [Related]
19. Flavonoids as a novel class of human organic anion-transporting polypeptide OATP1B1 (OATP-C) modulators. Wang X; Wolkoff AW; Morris ME Drug Metab Dispos; 2005 Nov; 33(11):1666-72. PubMed ID: 16081670 [TBL] [Abstract][Full Text] [Related]
20. Effects of Rifampin, a potent inducer of drug-metabolizing enzymes and an inhibitor of OATP1B1/3 transport, on the single dose pharmacokinetics of anacetrapib. Anderson MS; Cote J; Liu Y; Stypinski D; Auger P; Hohnstein A; Rasmussen S; Johnson-Levonas AO; Gutstein DE J Clin Pharmacol; 2013 Jul; 53(7):746-52. PubMed ID: 23670789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]